TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15520039

Group type: EXPERIMENTAL
Intervention: SkinWatch programme (community-based screening for melanoma)
Number of subjects: 16383
Study: 11584153

Group type: EXPERIMENTAL
Intervention: Biorad %CDT TIA assay
Number of subjects: 40

Group type: COMPARATOR
Intervention: GGT levels
Number of subjects: 40
Study: 9336959

Group type: EXPERIMENTAL
Intervention: Recognition tests instead of recall
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Word distractors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonword distractors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consonant string distractors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Strings of unfamiliar characters (false font)
Number of subjects: 0
Study: 7515387

Group type: COMPARATOR
Intervention: DHEA (50 mg nightly for 6 months)
Number of subjects: 30
Study: 3123249

Group type: EXPERIMENTAL
Intervention: Cortisol for 5 h
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Adrenaline for 1 h
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cortisol for 5 h with simultaneous adrenaline during the last hour
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo for 5 h
Number of subjects: 20
Study: 29329890

Group type: EXPERIMENTAL
Intervention: Not-painful eccentric exercise (NPEE)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Painful eccentric exercise (PEE)
Number of subjects: 22
Study: 26472406

Group type: EXPERIMENTAL
Intervention: Combination therapy with Ozurdex and macular laser therapy (MLT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: MLT only
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Combination therapy with Ozurdex and MLT
Number of subjects: 80
Study: 24683657

Group type: EXPERIMENTAL
Intervention: rhBMP-2/ACS
Number of subjects: 140

Group type: COMPARATOR
Intervention: ICBG
Number of subjects: 140
Study: 23516656

Group type: EXPERIMENTAL
Intervention: Integrated control strategy including praziquantel chemotherapy, controlling snails, building fences for bovines, safe pastures, and improving health conditions in six intervention villages.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group with routine interventions including praziquantel chemotherapy and controlling snails, without new interventions.
Number of subjects: 12
Study: 20005750

Group type: EXPERIMENTAL
Intervention: Systematic coronary angiography followed by PCI if needed (Group A)
Number of subjects: 426

Group type: COMPARATOR
Intervention: No preoperative coronary angiography (Group B)
Number of subjects: 426
Study: 19033012

Group type: EXPERIMENTAL
Intervention: Zofenopril (30 mg/d)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Enalapril (20 mg/d)
Number of subjects: 48
Study: 16630941

Group type: EXPERIMENTAL
Intervention: Codeine phosphate 60 mg
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 12715926

Group type: EXPERIMENTAL
Intervention: Tongue brushing (cared group)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Mouth rinsing (control group)
Number of subjects: 90
Study: 10975790

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 8843
Study: 8760738

Group type: EXPERIMENTAL
Intervention: Amoxycillin
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Penicillin V
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Combined Antibiotic Groups (Amoxycillin and Penicillin V)
Number of subjects: 130
Study: 1313765

Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg orally)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indomethacin (150 mg day-1 for three days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cyclosporine (5 mg kg-1 body weight for five days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (without nifedipine)
Number of subjects: 0
Study: 3860511

Group type: EXPERIMENTAL
Intervention: 0.02% stannous fluoride (SnF2) solution using Water Pik
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Water irrigation (H2O) using Water Pik
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no irrigation)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: SnF2 group after crossover
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Microbiologic data
Number of subjects: 28
Study: 30422367

Group type: COMPARATOR
Intervention: Intralesional triamcinolone alone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intralesional triamcinolone in combination with Botulinum Toxin A (BTA)
Number of subjects: 20
Study: 30001732

Group type: EXPERIMENTAL
Intervention: Acupuncture with deqi
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Acupuncture without deqi
Number of subjects: 105

Group type: COMPARATOR
Intervention: Wait-list group
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Functional magnetic resonance imaging (fMRI) scans
Number of subjects: 105
Study: 26541264

Group type: EXPERIMENTAL
Intervention: Azilsartan
Number of subjects: 2

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 2
Study: 24286443

Group type: EXPERIMENTAL
Intervention: High-cocoa flavanol (CF) intervention (375 mg CF, HiFI)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low-cocoa flavanol control (9 mg CF, LoFl)
Number of subjects: 16
Study: 22464260

Group type: EXPERIMENTAL
Intervention: MitraClip device treatment
Number of subjects: 264

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 264
Study: 20158897

Group type: EXPERIMENTAL
Intervention: Cognitive patient education intervention (up to four weekly sessions, each lasting 30 minutes)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Normal treatment (control group)
Number of subjects: 200
Study: 18084987

Group type: EXPERIMENTAL
Intervention: Superior subconjunctival anaesthesia (SCA)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Inferior subconjunctival anaesthesia (SCA)
Number of subjects: 99
Study: 16231532

Group type: EXPERIMENTAL
Intervention: Double dose of gadolinium (0.2 mmol/kg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Single dose of gadolinium (0.1 mmol/kg)
Number of subjects: 44
Study: 11877267

Group type: EXPERIMENTAL
Intervention: Intravenous unfractionated heparin (group A)
Number of subjects: 1048

Group type: EXPERIMENTAL
Intervention: Twice daily low‐molecular‐weight heparin (reviparin) for 1 week (group B)
Number of subjects: 1048

Group type: EXPERIMENTAL
Intervention: Once daily reviparin for 4 weeks (group C)
Number of subjects: 1048
Study: 9787298

Group type: EXPERIMENTAL
Intervention: Preoperative lung function (FEV1)
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Preoperative lung function (FVC)
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Preoperative physical functioning
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Smoking habit
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Quality of life (Medical Outcomes Study SF20)
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Psychosocial aspects (social functioning, role functioning, mental health, health perceptions, pain)
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Age, sex, body mass index, aneurysm diameter, graft type, hospital type, ECG characteristics, angina, previous myocardial infarction
Number of subjects: 474
Study: 7542589

Group type: EXPERIMENTAL
Intervention: 2 mg nicotine from nasal spray
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 2 mg nicotine from nasal spray with xylometazoline
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control session measurements in disease-free state
Number of subjects: 15
Study: 2675364

Group type: EXPERIMENTAL
Intervention: Antiembolism stockings
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: External pneumatic compression
Number of subjects: 70

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 70
Study: 401827

Group type: EXPERIMENTAL
Intervention: Disodium ethane‐1 hydroxy‐1, 1‐diphosphonate (EHDP) at doses of 0, 2.5, 5, 10, or 20 mg/kg/day (randomized)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Disodium ethane‐1 hydroxy‐1, 1‐diphosphonate (EHDP) at doses of 10 or 20 mg/kg/day (non-randomized)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Disodium ethane‐1 hydroxy‐1, 1‐diphosphonate (EHDP) at 5 mg/kg/day
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Disodium ethane‐1 hydroxy‐1, 1‐diphosphonate (EHDP) (various doses)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Disodium ethane‐1 hydroxy‐1, 1‐diphosphonate (EHDP) (higher doses)
Number of subjects: 75
Study: 31140596

Group type: EXPERIMENTAL
Intervention: MDZ‐NS 5 mg
Number of subjects: 262

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 262
Study: 28461862

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 for six months
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo for six months
Number of subjects: 25
Study: 24972700

Group type: EXPERIMENTAL
Intervention: Exercise training program (12 weeks) in SLE patients (SLE-TR, n = 17)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Exercise training program (12 weeks) in healthy controls (C-TR, n = 11)
Number of subjects: 33
Study: 23548119

Group type: EXPERIMENTAL
Intervention: Chinese medicine use
Number of subjects: 10287

Group type: EXPERIMENTAL
Intervention: Severe tiredness
Number of subjects: 10287
Study: 21675066

Group type: EXPERIMENTAL
Intervention: Mini-ventilation
Number of subjects: 38

Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 38
Study: 19762571

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin plus rifampin (CR)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin plus doxycycline (CD)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Doxycycline plus rifampin (DR)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: All groups (CR, CD, DR)
Number of subjects: 178
Study: 16926256

Group type: EXPERIMENTAL
Intervention: Aromatase inhibitor letrozole
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Spontaneous puberty in KS boys
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Healthy boys during puberty
Number of subjects: 44
Study: 15334794

Group type: EXPERIMENTAL
Intervention: TENS device 'Salutaris'
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 19
Study: 10942143

Group type: EXPERIMENTAL
Intervention: Bilateral injection of botulinum toxin (BOTOX) at a dosage of 2.5-U
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Unilateral injection of botulinum toxin (BOTOX) at a dosage of 15-U
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Bilateral and unilateral injections of botulinum toxin (BOTOX)
Number of subjects: 19
Study: 9111463

Group type: EXPERIMENTAL
Intervention: Nonsurgical interventions (multidisciplinary pain clinics, exercise, cognitive-behavioral strategies, etc.)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Nonsurgical interventions
Number of subjects: 35
Study: 8403290

Group type: EXPERIMENTAL
Intervention: Tallest height category (> or = 73 in. or 185.4 cm)
Number of subjects: 22071

Group type: COMPARATOR
Intervention: Shortest height category (< or = 67 in. or 170.2 cm)
Number of subjects: 22071

Group type: EXPERIMENTAL
Intervention: Height categories
Number of subjects: 22071
Study: 3536529

Group type: EXPERIMENTAL
Intervention: 7.5 mg once daily
Number of subjects: 23

Group type: COMPARATOR
Intervention: 2.5 mg three times daily
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Postponing the third dose until 10 p.m.
Number of subjects: 23
Study: 2901266

Group type: EXPERIMENTAL
Intervention: Betaxolol 10 to 40 mg once daily
Number of subjects: 141

Group type: COMPARATOR
Intervention: Propranolol 40 to 160 mg twice daily
Number of subjects: 141
Study: 31082951

Group type: EXPERIMENTAL
Intervention: Semiautomated imaging analysis software used to segment and quantify plaque features, with 14 imaging variables considered for ASCVD risk score prediction.
Number of subjects: 117
Study: 28365964

Group type: EXPERIMENTAL
Intervention: Irradiation stents (group A, N=18)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Ordinary stents (group B, N=25)
Number of subjects: 43
Study: 25313847

Group type: EXPERIMENTAL
Intervention: Peripheral nerve stimulation (PNS) of occipital nerves
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Higher number of prior PNS implants performed (NPPIP)
Number of subjects: 157
Study: 23953858

Group type: EXPERIMENTAL
Intervention: Music Therapy (MT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard Care (Control)
Number of subjects: 40
Study: 21715583

Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 3480

Group type: COMPARATOR
Intervention: NT-proBNP above the median
Number of subjects: 3480
Study: 18061828

Group type: EXPERIMENTAL
Intervention: Combination of amphotericin B (2.5 g) and itraconazole (6 months)
Number of subjects: 6
Study: 16836557

Group type: EXPERIMENTAL
Intervention: Perioperative iron sucrose (2 x 200 mg/48 hr, IV) plus preoperative erythropoietin (EPO; 1 x 40,000 UI, sc) for patients with preoperative Hb < 130 g/L (Group A)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Postoperative unwashed shed blood (USB) for patients with preoperative Hb < 130 g/L (Group B)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 312
Study: 12569270

Group type: EXPERIMENTAL
Intervention: Transdermal estrogen (17 beta‐estradiol, 100 microg/24 h)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 10863568

Group type: EXPERIMENTAL
Intervention: Nutrition newsletters with follow-up telephone interviews
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Nutrition newsletters only
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Both treatment groups (newsletters with and without telephone interviews)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Control group (pretest-posttest surveys only)
Number of subjects: 480
Study: 9114765

Group type: EXPERIMENTAL
Intervention: Atenolol (50 or 100 mg once daily)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Enalapril (10 or 20 mg once daily)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 1350338

Group type: EXPERIMENTAL
Intervention: Hypnosis training (HYP)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral coping skills training (CB)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Therapist contact control (TC)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 67
Study: 3519549

Group type: EXPERIMENTAL
Intervention: Halsted mastectomy
Number of subjects: 701

Group type: COMPARATOR
Intervention: QUART (quadrantectomy with axillary dissection and radiotherapy)
Number of subjects: 701
Study: 30026341

Group type: COMPARATOR
Intervention: Cytarabine
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: Arsenic
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: All-trans retinoic acid
Number of subjects: 795

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus arsenic
Number of subjects: 795
Study: 27423645

Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiotherapy
Number of subjects: 338

Group type: COMPARATOR
Intervention: Conventional radiotherapy
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Focal radiotherapy (RT)
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: High dose chemotherapy with stem cell rescue (HDSCR)
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Conventional chemotherapy
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Overall survival (OS) after relapse
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Late relapse (>5 years from diagnosis)
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Isolated local relapses in the posterior fossa (PF)
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Craniospinal, metastatic relapses
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Exploration of new drugs
Number of subjects: 338
Study: 23647413

Group type: EXPERIMENTAL
Intervention: Number changes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cumulative area changes
Number of subjects: 0
Study: 23559791

Group type: EXPERIMENTAL
Intervention: Guduchyadi Medhya Rasayana
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 138
Study: 20438395

Group type: EXPERIMENTAL
Intervention: ASPI-test after pneumatic tube delivery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TRAP-test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Normalisation of the ASPI-test result using the TRAP-test result
Number of subjects: 0
Study: 18457472

Group type: EXPERIMENTAL
Intervention: Bazedoxifene (10, 20 and 40 mg)
Number of subjects: 7492

Group type: EXPERIMENTAL
Intervention: Bazedoxifene
Number of subjects: 7492

Group type: COMPARATOR
Intervention: Raloxifene (60 mg)
Number of subjects: 7492

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7492
Study: 16995893

Group type: EXPERIMENTAL
Intervention: 6-month clinical intervention (4 contacts) to facilitate internalization of autonomy and perceived competence for tobacco abstinence and reduced percent calories from fat.
Number of subjects: 1006

Group type: COMPARATOR
Intervention: Community care (control group).
Number of subjects: 1006
Study: 12424044

Group type: EXPERIMENTAL
Intervention: 5 mg morphine in 20 ml normal saline (Group B)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 15 mg morphine in 20 ml normal saline (Group C)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 20 ml normal saline (Group A)
Number of subjects: 30
Study: 10433851

Group type: EXPERIMENTAL
Intervention: Primary open‐angle glaucoma (POAG)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Normal controls (N)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Normal-pressure glaucoma (NPG)
Number of subjects: 75
Study: 8585189

Group type: EXPERIMENTAL
Intervention: 1 unit fresh whole blood (FWB)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 1 unit irradiated fresh whole blood (IrFWB, 1,500 cGy)
Number of subjects: 24
Study: 2186991

Group type: EXPERIMENTAL
Intervention: Pirbuterol administered via the Autohaler
Number of subjects: 13

Group type: COMPARATOR
Intervention: Salbutamol administered via the Diskhaler
Number of subjects: 13
Study: 6777263

Group type: EXPERIMENTAL
Intervention: Oral sodium cromoglycate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31120601

Group type: EXPERIMENTAL
Intervention: De-escalated radiation therapy (<66 Gy)
Number of subjects: 1168

Group type: COMPARATOR
Intervention: Full-dose radiation therapy (≥66 Gy)
Number of subjects: 1168
Study: 29191811

Group type: EXPERIMENTAL
Intervention: Laerdal Upright Resuscitator with snap-fit mask
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Standard Laerdal infant resuscitator with snap-fit mask
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: T-Piece Resuscitator (Neopuff) with snap-fit mask
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard Laerdal infant resuscitator with standard mask
Number of subjects: 40

Group type: COMPARATOR
Intervention: T-Piece Resuscitator (Neopuff) with standard mask
Number of subjects: 40

Group type: COMPARATOR
Intervention: Laerdal Upright Resuscitator with standard mask
Number of subjects: 40
Study: 27241374

Group type: EXPERIMENTAL
Intervention: Direct Anterior (DA) approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Direct Lateral approach
Number of subjects: 0
Study: 25409738

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g by intravenous injection followed by 3 g intravenous infusion over 24 hours)
Number of subjects: 8000

Group type: COMPARATOR
Intervention: Placebo (sodium chloride 0.9%)
Number of subjects: 8000
Study: 22772170

Group type: EXPERIMENTAL
Intervention: MMRV vaccine (2-dose regimen at a 1-month interval)
Number of subjects: 3388
Study: 20142523

Group type: EXPERIMENTAL
Intervention: Latrepirdine, 20 mg 3 times daily (n = 46)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo (n = 45)
Number of subjects: 91
Study: 17477888

Group type: EXPERIMENTAL
Intervention: Agomelatine 25 mg/d (with dose adjustment to 50 mg/d if insufficient improvement)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 238
Study: 15618254

Group type: EXPERIMENTAL
Intervention: Two cycles with single embryo transfer (SET)
Number of subjects: 107

Group type: COMPARATOR
Intervention: One cycle with double embryo transfer (DET)
Number of subjects: 107
Study: 12137873

Group type: EXPERIMENTAL
Intervention: Tibolone (2.5 mg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conjugated equine estrogens (0.625 mg/d) plus medroxyprogesterone acetate (5 mg/d)
Number of subjects: 0
Study: 9744696

Group type: EXPERIMENTAL
Intervention: Somatostatin
Number of subjects: 73

Group type: COMPARATOR
Intervention: Ranitidine
Number of subjects: 73

Group type: COMPARATOR
Intervention: Omeprazole
Number of subjects: 73
Study: 8039940

Group type: EXPERIMENTAL
Intervention: Pulsatile perfusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cardiopulmonary bypass (CPB)
Number of subjects: 0
Study: 2722722

Group type: EXPERIMENTAL
Intervention: Cefmetazole
Number of subjects: 49

Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 49
Study: 29424236

Group type: EXPERIMENTAL
Intervention: Psychological intervention (up to 10 sessions based on cognitive behavioural therapy) plus usual care
Number of subjects: 51

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 51
Study: 28822518

Group type: EXPERIMENTAL
Intervention: FFR>0.8 and kept on medical follow-up
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: FFR≤0.8 and underwent revascularisation (PCI in 144 & CABG in 31)
Number of subjects: 282

Group type: COMPARATOR
Intervention: FFR≤0.8 and refused to undergo revascularisation
Number of subjects: 282
Study: 25521788

Group type: EXPERIMENTAL
Intervention: Computer simulation program for personal protective equipment training (experimental group)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional personal protective equipment training only (control group)
Number of subjects: 50
Study: 23517767

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention coordinated by a Nutritional Support Team (NST) including access to a computerized malnutrition screening system, awareness campaign, and leadership strategy
Number of subjects: 1289

Group type: COMPARATOR
Intervention: Control group (not explicitly detailed in the abstract)
Number of subjects: 1289